These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32622686)

  • 1. The authors' response: A diagnostic confusion between serotonin syndrome and neuroleptic malignant syndrome.
    Soh M; Hifumi T; Isokawa S; Shimizu M; Otani N; Ishimatsu S
    Am J Emerg Med; 2021 May; 43():274. PubMed ID: 32622686
    [No Abstract]   [Full Text] [Related]  

  • 2. A diagnostic confusion between Serotonin syndrome and Neuroleptic malignant syndrome.
    Prakash S
    Am J Emerg Med; 2021 May; 43():272-273. PubMed ID: 33008703
    [No Abstract]   [Full Text] [Related]  

  • 3. A Mixed Presentation of Serotonin Syndrome Versus Neuroleptic Malignant Syndrome in a 12-Year-Old Boy.
    Ott M; Werneke U
    Pediatr Emerg Care; 2019 May; 35(5):e98. PubMed ID: 30964850
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuroleptic Malignant Syndrome or Serotonin Syndrome?
    Nagamine T
    Psychiatr Danub; 2022; 34(3):526-527. PubMed ID: 36256997
    [No Abstract]   [Full Text] [Related]  

  • 5. Comment: Neuroleptic malignant syndrome versus serotonin syndrome: the search for a diagnostic tool.
    Darracq MA
    Ann Pharmacother; 2012 Apr; 46(4):611-2; author reply 613. PubMed ID: 22414789
    [No Abstract]   [Full Text] [Related]  

  • 6. Comment: Neuroleptic malignant syndrome versus serotonin syndrome: the search for a diagnostic tool.
    Sanaei-Zadeh H
    Ann Pharmacother; 2012 Apr; 46(4):612; author reply 613. PubMed ID: 22414792
    [No Abstract]   [Full Text] [Related]  

  • 7. Distinguishing between Neuroleptic Malignant Syndrome and Serotonin Syndrome in Polypharmacy: An Overview with a Case Report.
    Debeljak T; Kores Plesničar B
    Psychiatr Danub; 2021; 33(Suppl 4):1227-1229. PubMed ID: 35354191
    [No Abstract]   [Full Text] [Related]  

  • 8. Serotonin syndrome versus neuroleptic malignant syndrome: a challenging clinical quandary.
    Dosi R; Ambaliya A; Joshi H; Patell R
    BMJ Case Rep; 2014 Jun; 2014():. PubMed ID: 24957740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin syndrome and other serotonergic disorders.
    Ener RA; Meglathery SB; Van Decker WA; Gallagher RM
    Pain Med; 2003 Mar; 4(1):63-74. PubMed ID: 12873279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroleptic malignant syndrome versus serotonin syndrome: the search for a diagnostic tool.
    Sokoro AA; Zivot J; Ariano RE
    Ann Pharmacother; 2011 Sep; 45(9):e50. PubMed ID: 21878660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Malignant neuroleptic syndrome or serotonergic syndrome].
    Christensen V; Glenthøj BY
    Ugeskr Laeger; 2001 Jan; 163(3):301-2. PubMed ID: 11219110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are neuroleptic malignant syndrome and serotonin syndrome the same syndrome?
    Steele D; Keltner NL; McGuiness TM
    Perspect Psychiatr Care; 2011 Jan; 47(1):58-62. PubMed ID: 21418073
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnosing neuroleptic malignant syndrome.
    Gruber MP
    Chest; 2004 May; 125(5):1960-1; author reply 1961. PubMed ID: 15136417
    [No Abstract]   [Full Text] [Related]  

  • 14. Serotonin syndrome vs neuroleptic malignant syndrome: a contrast of causes, diagnoses, and management.
    Perry PJ; Wilborn CA
    Ann Clin Psychiatry; 2012 May; 24(2):155-62. PubMed ID: 22563571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexistence of serotonin syndrome and neuroleptic malignant syndrome: does it exist?
    Prakash S; Lodha D; Rawat KS
    BMJ Case Rep; 2021 Aug; 14(8):. PubMed ID: 34400419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroleptic malignant syndrome in COVID-19 patients by Soh et al.
    Ubhayakar N; Liu A
    Am J Emerg Med; 2021 May; 43():259. PubMed ID: 32650958
    [No Abstract]   [Full Text] [Related]  

  • 17. Atypical neuroleptic malignant syndrome or serotonin toxicity associated with atypical antipsychotics?
    Odagaki Y
    Curr Drug Saf; 2009 Jan; 4(1):84-93. PubMed ID: 19149529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroleptic malignant syndrome and serotonin syndrome.
    Tormoehlen LM; Rusyniak DE
    Handb Clin Neurol; 2018; 157():663-675. PubMed ID: 30459031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evaluation and management of patients with neuroleptic malignant syndrome.
    Bhanushali MJ; Tuite PJ
    Neurol Clin; 2004 May; 22(2):389-411. PubMed ID: 15062519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case files of the program in medical toxicology at brown university: amantadine withdrawal and the neuroleptic malignant syndrome.
    Brantley E; Cohn J; Babu K
    J Med Toxicol; 2009 Jun; 5(2):92-8. PubMed ID: 19415596
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.